Navigation Links
Young scientists turn to gel to ease side-effects of cancer treatment

Three young scientists in the University of York's Department of Chemistry have developed a gel that could spare cancer patients some of the unpleasant and dangerous side-effects of radiotherapy.

PhD students Andrew Wilson and Paul Watson, together with post-doctoral research fellow Mark Godber, have developed the gel which will help doctors to target cancer tumours more efficiently.

Now, the group has secured £30,000 under the Bioscience Yorkshire Enterprise Fellowship scheme to commercialise their idea.

Their product, a formulation of various chemicals, is a gelatine whose density is comparable with human tissue and can be tailored for different applications.

"This technique should allow more rapid, accurate, and therefore safer treatment of malignant tumours" Andrew Wilson. The density of the gel alters when subjected to radiation beams, so radiologists can use it to take the guesswork out of the intensity-modulated radiation therapy treatment of malignant cancers.

By testing the radiation beam on the gel first, radiologists can judge more accurately the precise dose needed to treat the tumour, enabling them to calibrate their machines accordingly.

Andrew Wilson said: "This technique should allow more rapid, accurate, and therefore safer treatment of malignant tumours."

A different formula of the gel can be used as a phantom in the detection of brain tumours. Working with researchers at the Centre for Magnetic Resonance Investigations, at Hull Royal Infirmary, the team has developed a technique which uses the gel to improve the accuracy of targeting tumour cells.

Magnetic Resonance Spectroscopy can be used as an imaging technique allowing the tumour to be identified accurately, because of the differing biological activity in tumour cells compared with healthy cells. A phantom is required to prove the accuracy of these measurements.

The team has already supplied samples of the gels to the Princess Royal Hospital in Hull and hope to go into commercial production soon.


'"/>

Source:University of York


Related biology news :

1. Young Blood Revives Aging Muscles, Stanford Researchers Find
2. Wisconsin scientists grow critical nerve cells
3. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
4. UAB scientists discover the origin of a mysterious physical force
5. Fox Chase Cancer Center scientists identify immune-system mutation
6. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
7. U-M scientists find genes that control growth of common skin cancer
8. UCLA scientists transform HIV into cancer-seeking missile
9. RNA project to create language for scientists worldwide
10. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
11. To control germs, scientists deploy tiny agents provocateurs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... ... August 13, 2018 , ... ... and explore opportunities with multiple health systems at once. However, healthcare professionals often ... offer another, more efficient option for healthcare providers who wish to explore opportunities ...
(Date:8/14/2018)... , ... August 14, 2018 , ... ... compliance and commercialization, is announcing the keynote for their NAVIGATE2018 conference. ... announced as keynote speaker for NAVIGATE2018 , Cognition’s annual user conference. An ...
(Date:8/7/2018)... ... August 06, 2018 , ... Nurse ... remained generally satisfied with their healthcare careers in the past year, according to ... provides healthcare employers and jobseekers with a wide variety of career- and employment-related ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... WALTHAM, MAss. (PRWEB) , ... August 09, 2018 ... ... diverse group of architectural, engineering, and construction (AEC) experts with building owners and ... New England. The fourth-annual Create + Construct symposium comes to Boston for the ...
(Date:7/31/2018)... ... July 31, 2018 , ... ... molecular quality controls to its expanding CE/IVD product inventory. , “We are pleased ... CE/IVD QC offerings. ZeptoMetrix remains entirely committed to fully support and provide our ...
(Date:7/25/2018)... ... July 25, 2018 , ... Dimitrius Anagnos, an ... to combat inflammation and autoimmune disorders. , The preclinical research assessed biomarkers ... data was reported:, Over 70% decrease in Interleukin ...
(Date:7/24/2018)... ... July 23, 2018 , ... Mark Stutheit, an evidence-based ... increase immunity and improve anti-inflammatory, and immune function responses. , Biomarkers for systemic ... research were significantly reduced. Results are as follows:, , ...
Breaking Biology Technology: